https://www.selleckchem.com/pr....oducts/ins018-055-is
nti-cholesterol and antioxidant potentialities. Lung cancer is the leading cause of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD) is one of the main subtypes of lung cancer. Hundreds of metabolic genes are altered consistently in LUAD; however, their prognostic role remains to be explored. This study aimed to establish a molecular signature that can predict the prognosis in patients with LUAD based on metabolic gene expression. The transcriptome expression profiles and corresponding clinical information of LU
Like
Comment
Share
